[1]
P. K. A, P. G, M. Sn, S. Ap, V. Swamy, and S. Rama, “CLINICAL OUTCOMES OF USE OF HYDROXYCHLOROQUINE IN PARADOXICAL TUBERCULOSIS-IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME IN HIV-INFECTED PATIENTS”., Asian J Pharm Clin Res, vol. 11, no. 2, pp. 439–441, Feb. 2018.